 | • レポートコード：QFJ1-5632 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、植物＆植物誘導体医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（処方薬、OTC）、用途別市場規模（循環器、腫瘍、呼吸器系、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・植物＆植物誘導体医薬品の市場動向 ・企業の競争状況、市場シェア ・植物＆植物誘導体医薬品の種類別市場規模と予測2016-2027（処方薬、OTC） ・植物＆植物誘導体医薬品の用途別市場規模と予測2016-2027（循環器、腫瘍、呼吸器系、その他） ・植物＆植物誘導体医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・植物＆植物誘導体医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・植物＆植物誘導体医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・植物＆植物誘導体医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・植物＆植物誘導体医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Buchang Pharmaceuticals、China TCM、Tsumura、Schwabe、Tong Ren Tang、Jumpcan Pharmaceutical、Guangzhou Baiyunshan Pharmaceutical、Yunnan Baiyao、Tasly Holding Group、Bionorica Se、Huarun 999、Taiji、Weleda、Kwangdong、GW Pharmaceuticals） ・結論 |
A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
Market Analysis and Insights: Global Botanical and Plant Derivative Drug Market
The global Botanical and Plant Derivative Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Botanical and Plant Derivative Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Botanical and Plant Derivative Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Botanical and Plant Derivative Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Botanical and Plant Derivative Drug market.
Global Botanical and Plant Derivative Drug Scope and Market Size
Botanical and Plant Derivative Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Botanical and Plant Derivative Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Prescription Drug
OTC
Segment by Application
Cardiovascular
Tumor
Respiratory System
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical and Plant Derivative Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical and Plant Derivative Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Botanical and Plant Derivative Drug Market Perspective (2016-2027)
2.2 Botanical and Plant Derivative Drug Growth Trends by Regions
2.2.1 Botanical and Plant Derivative Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Botanical and Plant Derivative Drug Historic Market Share by Regions (2016-2021)
2.2.3 Botanical and Plant Derivative Drug Forecasted Market Size by Regions (2022-2027)
2.3 Botanical and Plant Derivative Drug Industry Dynamic
2.3.1 Botanical and Plant Derivative Drug Market Trends
2.3.2 Botanical and Plant Derivative Drug Market Drivers
2.3.3 Botanical and Plant Derivative Drug Market Challenges
2.3.4 Botanical and Plant Derivative Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical and Plant Derivative Drug Players by Revenue
3.1.1 Global Top Botanical and Plant Derivative Drug Players by Revenue (2016-2021)
3.1.2 Global Botanical and Plant Derivative Drug Revenue Market Share by Players (2016-2021)
3.2 Global Botanical and Plant Derivative Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Botanical and Plant Derivative Drug Revenue
3.4 Global Botanical and Plant Derivative Drug Market Concentration Ratio
3.4.1 Global Botanical and Plant Derivative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical and Plant Derivative Drug Revenue in 2020
3.5 Botanical and Plant Derivative Drug Key Players Head office and Area Served
3.6 Key Players Botanical and Plant Derivative Drug Product Solution and Service
3.7 Date of Enter into Botanical and Plant Derivative Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical and Plant Derivative Drug Breakdown Data by Type
4.1 Global Botanical and Plant Derivative Drug Historic Market Size by Type (2016-2021)
4.2 Global Botanical and Plant Derivative Drug Forecasted Market Size by Type (2022-2027)
5 Botanical and Plant Derivative Drug Breakdown Data by Application
5.1 Global Botanical and Plant Derivative Drug Historic Market Size by Application (2016-2021)
5.2 Global Botanical and Plant Derivative Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Botanical and Plant Derivative Drug Market Size (2016-2027)
6.2 North America Botanical and Plant Derivative Drug Market Size by Type
6.2.1 North America Botanical and Plant Derivative Drug Market Size by Type (2016-2021)
6.2.2 North America Botanical and Plant Derivative Drug Market Size by Type (2022-2027)
6.2.3 North America Botanical and Plant Derivative Drug Market Size by Type (2016-2027)
6.3 North America Botanical and Plant Derivative Drug Market Size by Application
6.3.1 North America Botanical and Plant Derivative Drug Market Size by Application (2016-2021)
6.3.2 North America Botanical and Plant Derivative Drug Market Size by Application (2022-2027)
6.3.3 North America Botanical and Plant Derivative Drug Market Size by Application (2016-2027)
6.4 North America Botanical and Plant Derivative Drug Market Size by Country
6.4.1 North America Botanical and Plant Derivative Drug Market Size by Country (2016-2021)
6.4.2 North America Botanical and Plant Derivative Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Botanical and Plant Derivative Drug Market Size (2016-2027)
7.2 Europe Botanical and Plant Derivative Drug Market Size by Type
7.2.1 Europe Botanical and Plant Derivative Drug Market Size by Type (2016-2021)
7.2.2 Europe Botanical and Plant Derivative Drug Market Size by Type (2022-2027)
7.2.3 Europe Botanical and Plant Derivative Drug Market Size by Type (2016-2027)
7.3 Europe Botanical and Plant Derivative Drug Market Size by Application
7.3.1 Europe Botanical and Plant Derivative Drug Market Size by Application (2016-2021)
7.3.2 Europe Botanical and Plant Derivative Drug Market Size by Application (2022-2027)
7.3.3 Europe Botanical and Plant Derivative Drug Market Size by Application (2016-2027)
7.4 Europe Botanical and Plant Derivative Drug Market Size by Country
7.4.1 Europe Botanical and Plant Derivative Drug Market Size by Country (2016-2021)
7.4.2 Europe Botanical and Plant Derivative Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Botanical and Plant Derivative Drug Market Size (2016-2027)
8.2 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Type
8.2.1 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Application
8.3.1 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region
8.4.1 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Botanical and Plant Derivative Drug Market Size (2016-2027)
9.2 Latin America Botanical and Plant Derivative Drug Market Size by Type
9.2.1 Latin America Botanical and Plant Derivative Drug Market Size by Type (2016-2021)
9.2.2 Latin America Botanical and Plant Derivative Drug Market Size by Type (2022-2027)
9.2.3 Latin America Botanical and Plant Derivative Drug Market Size by Type (2016-2027)
9.3 Latin America Botanical and Plant Derivative Drug Market Size by Application
9.3.1 Latin America Botanical and Plant Derivative Drug Market Size by Application (2016-2021)
9.3.2 Latin America Botanical and Plant Derivative Drug Market Size by Application (2022-2027)
9.3.3 Latin America Botanical and Plant Derivative Drug Market Size by Application (2016-2027)
9.4 Latin America Botanical and Plant Derivative Drug Market Size by Country
9.4.1 Latin America Botanical and Plant Derivative Drug Market Size by Country (2016-2021)
9.4.2 Latin America Botanical and Plant Derivative Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical and Plant Derivative Drug Market Size (2016-2027)
10.2 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Type
10.2.1 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Application
10.3.1 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country
10.4.1 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Details
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical and Plant Derivative Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Details
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical and Plant Derivative Drug Introduction
11.2.4 China TCM Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Details
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical and Plant Derivative Drug Introduction
11.3.4 Tsumura Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Details
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical and Plant Derivative Drug Introduction
11.4.4 Schwabe Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Details
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical and Plant Derivative Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Details
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical and Plant Derivative Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Details
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical and Plant Derivative Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Details
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical and Plant Derivative Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Details
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical and Plant Derivative Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Details
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical and Plant Derivative Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Details
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical and Plant Derivative Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Details
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical and Plant Derivative Drug Introduction
11.12.4 Taiji Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Details
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical and Plant Derivative Drug Introduction
11.13.4 Weleda Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Details
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical and Plant Derivative Drug Introduction
11.14.4 Kwangdong Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Details
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical and Plant Derivative Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2016-2021)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Botanical and Plant Derivative Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC
Table 4. Global Botanical and Plant Derivative Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Botanical and Plant Derivative Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Botanical and Plant Derivative Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Botanical and Plant Derivative Drug Market Share by Regions (2016-2021)
Table 8. Global Botanical and Plant Derivative Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Botanical and Plant Derivative Drug Market Share by Regions (2022-2027)
Table 10. Botanical and Plant Derivative Drug Market Trends
Table 11. Botanical and Plant Derivative Drug Market Drivers
Table 12. Botanical and Plant Derivative Drug Market Challenges
Table 13. Botanical and Plant Derivative Drug Market Restraints
Table 14. Global Botanical and Plant Derivative Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Botanical and Plant Derivative Drug Market Share by Players (2016-2021)
Table 16. Global Top Botanical and Plant Derivative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botanical and Plant Derivative Drug as of 2020)
Table 17. Ranking of Global Top Botanical and Plant Derivative Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Botanical and Plant Derivative Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Botanical and Plant Derivative Drug Product Solution and Service
Table 21. Date of Enter into Botanical and Plant Derivative Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Botanical and Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Botanical and Plant Derivative Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Botanical and Plant Derivative Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Botanical and Plant Derivative Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Botanical and Plant Derivative Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Botanical and Plant Derivative Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Botanical and Plant Derivative Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Botanical and Plant Derivative Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Botanical and Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Botanical and Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Botanical and Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Botanical and Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Botanical and Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Botanical and Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Botanical and Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Botanical and Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Botanical and Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Botanical and Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Botanical and Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Botanical and Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Botanical and Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Botanical and Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Botanical and Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Botanical and Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Botanical and Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Botanical and Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Buchang Pharmaceuticals Company Details
Table 62. Buchang Pharmaceuticals Business Overview
Table 63. Buchang Pharmaceuticals Botanical and Plant Derivative Drug Product
Table 64. Buchang Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 65. Buchang Pharmaceuticals Recent Development
Table 66. China TCM Company Details
Table 67. China TCM Business Overview
Table 68. China TCM Botanical and Plant Derivative Drug Product
Table 69. China TCM Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 70. China TCM Recent Development
Table 71. Tsumura Company Details
Table 72. Tsumura Business Overview
Table 73. Tsumura Botanical and Plant Derivative Drug Product
Table 74. Tsumura Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 75. Tsumura Recent Development
Table 76. Schwabe Company Details
Table 77. Schwabe Business Overview
Table 78. Schwabe Botanical and Plant Derivative Drug Product
Table 79. Schwabe Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 80. Schwabe Recent Development
Table 81. Tong Ren Tang Company Details
Table 82. Tong Ren Tang Business Overview
Table 83. Tong Ren Tang Botanical and Plant Derivative Drug Product
Table 84. Tong Ren Tang Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 85. Tong Ren Tang Recent Development
Table 86. Jumpcan Pharmaceutical Company Details
Table 87. Jumpcan Pharmaceutical Business Overview
Table 88. Jumpcan Pharmaceutical Botanical and Plant Derivative Drug Product
Table 89. Jumpcan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 90. Jumpcan Pharmaceutical Recent Development
Table 91. Guangzhou Baiyunshan Pharmaceutical Company Details
Table 92. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 93. Guangzhou Baiyunshan Pharmaceutical Botanical and Plant Derivative Drug Product
Table 94. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 95. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 96. Yunnan Baiyao Company Details
Table 97. Yunnan Baiyao Business Overview
Table 98. Yunnan Baiyao Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 99. Yunnan Baiyao Recent Development
Table 100. Tasly Holding Group Company Details
Table 101. Tasly Holding Group Business Overview
Table 102. Tasly Holding Group Botanical and Plant Derivative Drug Product
Table 103. Tasly Holding Group Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 104. Tasly Holding Group Recent Development
Table 105. Bionorica Se Company Details
Table 106. Bionorica Se Business Overview
Table 107. Bionorica Se Botanical and Plant Derivative Drug Product
Table 108. Bionorica Se Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 109. Bionorica Se Recent Development
Table 110. Huarun 999 Company Details
Table 111. Huarun 999 Business Overview
Table 112. Huarun 999 Botanical and Plant Derivative Drug Product
Table 113. Huarun 999 Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 114. Huarun 999 Recent Development
Table 115. Taiji Company Details
Table 116. Taiji Business Overview
Table 117. Taiji Botanical and Plant Derivative Drug Product
Table 118. Taiji Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 119. Taiji Recent Development
Table 120. Weleda Company Details
Table 121. Weleda Business Overview
Table 122. Weleda Botanical and Plant Derivative Drug Product
Table 123. Weleda Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 124. Weleda Recent Development
Table 125. Kwangdong Company Details
Table 126. Kwangdong Business Overview
Table 127. Kwangdong Botanical and Plant Derivative Drug Product
Table 128. Kwangdong Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 129. Kwangdong Recent Development
Table 130. GW Pharmaceuticals Company Details
Table 131. GW Pharmaceuticals Business Overview
Table 132. GW Pharmaceuticals Botanical and Plant Derivative Drug Product
Table 133. GW Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2016-2021) & (US$ Million)
Table 134. GW Pharmaceuticals Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botanical and Plant Derivative Drug Market Share by Type: 2020 VS 2027
Figure 2. Prescription Drug Features
Figure 3. OTC Features
Figure 4. Global Botanical and Plant Derivative Drug Market Share by Application: 2020 VS 2027
Figure 5. Cardiovascular Case Studies
Figure 6. Tumor Case Studies
Figure 7. Respiratory System Case Studies
Figure 8. Other Case Studies
Figure 9. Botanical and Plant Derivative Drug Report Years Considered
Figure 10. Global Botanical and Plant Derivative Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Botanical and Plant Derivative Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Botanical and Plant Derivative Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Botanical and Plant Derivative Drug Market Share by Regions (2022-2027)
Figure 14. Global Botanical and Plant Derivative Drug Market Share by Players in 2020
Figure 15. Global Top Botanical and Plant Derivative Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Botanical and Plant Derivative Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Botanical and Plant Derivative Drug Revenue in 2020
Figure 17. Global Botanical and Plant Derivative Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Botanical and Plant Derivative Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Botanical and Plant Derivative Drug Market Share by Type (2016-2027)
Figure 21. North America Botanical and Plant Derivative Drug Market Share by Application (2016-2027)
Figure 22. North America Botanical and Plant Derivative Drug Market Share by Country (2016-2027)
Figure 23. United States Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Botanical and Plant Derivative Drug Market Share by Type (2016-2027)
Figure 27. Europe Botanical and Plant Derivative Drug Market Share by Application (2016-2027)
Figure 28. Europe Botanical and Plant Derivative Drug Market Share by Country (2016-2027)
Figure 29. Germany Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Botanical and Plant Derivative Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Botanical and Plant Derivative Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Botanical and Plant Derivative Drug Market Share by Region (2016-2027)
Figure 39. China Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Botanical and Plant Derivative Drug Market Share by Type (2016-2027)
Figure 47. Latin America Botanical and Plant Derivative Drug Market Share by Application (2016-2027)
Figure 48. Latin America Botanical and Plant Derivative Drug Market Share by Country (2016-2027)
Figure 49. Mexico Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Botanical and Plant Derivative Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Botanical and Plant Derivative Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Botanical and Plant Derivative Drug Market Share by Country (2016-2027)
Figure 55. Turkey Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Botanical and Plant Derivative Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Buchang Pharmaceuticals Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 59. China TCM Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 60. Tsumura Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 61. Schwabe Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 62. Tong Ren Tang Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 63. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 64. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 65. Yunnan Baiyao Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 66. Tasly Holding Group Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 67. Bionorica Se Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 68. Huarun 999 Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 69. Taiji Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 70. Weleda Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 71. Kwangdong Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 72. GW Pharmaceuticals Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の植物性薬市場規模・現状・予測（2021年-2027年） A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans. Market Analysis and Insights: Global Plant Derivative Drug Market The global Plant Derivative Drug market size is projected to reach US$ XX million by 2027, from US$ XX mill…- 世界の植物抽出薬市場規模・現状・予測（2021年-2027年） A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans. Market Analysis and Insights: Global Plant Extract Drug Market The global Plant Extract Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in…
- 世界のホップ誘導体産業調査2019-2025 Hops are the flowers of the hops plant Humulus lupulus. Hops are primarily used as stabilizing agent in beer and it gives a bitter taste to the product. Its derivatives are compounds, which are synthesized by chemical processes to produce one or more compound having similar structural homology to a …
- 世界のホップ誘導体産業調査2019-2025 Hops are the flowers of the hops plant Humulus lupulus. Hops are primarily used as stabilizing agent in beer and it gives a bitter taste to the product. Its derivatives are compounds, which are synthesized by chemical processes to produce one or more compound having similar structural homology to a …
- 世界の大豆誘導体産業調査2019-2025 Soy derivatives are processed from raw soybeans and include soy oil, soy meal, soy protein, and soy milk.In 2018, the global Soy Derivative market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base…